Learning Objectives: -Review the metabolic risk factors and screening criteria to identify and stratify patients at risk for MASLD/MASH. -Describe how and when to use non-invasive diagnostics to diagnose, stage, and monitor progress/response in MASLD/MASH. -Define current guidelines and care pathways for therapeutic options tailored to patient stage of disease, risk factors, comorbidities, preferences, capabilities, and circumstances. -Evaluate the efficacy of emerging pharmacologic therapies in the medical management of MASLD/MASH.
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/courses
- Start Date: 2024-06-13 05:00:00
- End Date: 2024-06-13 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 274750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Endocrinology, Diabetes, and Metabolism, Internal Medicine
Subscribe
Login
0 Comments
Oldest